UPMC Hillman Cancer Center

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the Hillman CCSG support, and they are tracking compliance. If a Hillman CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the Hillman CCSG support.

Contact & Scheduling

The Biostatistics Facility has ongoing work on numerous projects. Thus, an investigator should allow appropriate time to complete the work requested.

For new projects, we will ordinarily need an initial meeting to discuss the project's background and some of the details relating to our involvement in it. For example, before developing the statistical section for a research grant proposal or a clinical trial, or initiating statistical analyses, we will work with the investigator to clarify the:

  • objectives of study,
  • key endpoints for analysis,
  • study design and conduct, and
  • issues to be addressed by statistical analysis.

Members of the BF have expertise in different disease sites and treatment methods, and their specialties are listed on the Personnel page. If your area of research is not included, or if you are not sure who to contact, please contact the Director to identify a statistical collaborator.


The BF gives highest priority to development and work on basic science, translational, therapeutic, and cancer control / population science studies having or seeking research funding from the NCI or equivalent funding agencies.

Equally important is our support of UPMC Hillman Cancer Center's clinical trial activities through service on its Protocol Review Committees, Data and Safety Monitoring Committee, and Clinical Research Oversight Committee.

A second tier of priorities involves development and work on investigator-initiated industry-sponsored oncology clinical trials evaluating novel therapeutic agents or treatment modalities.

Other cancer-related work intended for publication in peer-reviewed journals, such as unfunded studies based on meta-analyses, chart reviews, or various databases, is addressed on a time-available basis.

No support for non-members is provided, except for work being done in direct collaboration with a UPMC Hillman Cancer Center member on a cancer-related project.

Data Submission

Please see the Spreadsheet Example for Response, PFS & OS.


Facility Director

Daniel P. Normolle, PhD
Associate Professor, Department of Biostatistics
Director, UPMC Hillman Cancer Center Biostatistics Facility
Phone: 412-383-1591
Email: dpn7@pitt.edu

Judy Hreha
Phone: 412-383-1537
Email: jah57@pitt.edu

UPMC Hillman Cancer Center Biostatistics Facility

Sterling Plaza Suite 325
201 North Craig Street
Pittsburgh, PA 15213
Phone: 412-383-1537
Fax: 412-383-1535